TRAVELERS COMPANIES, INC. (TRV) Insider Transactions
Explore official ownership filings, with every record linked to its source.
TRV · TRAVELERS COMPANIES, INC.
How to read this data ↗Recent reported activity
Purchases and sales count original non-derivative P and S rows. Awards, gifts, exercises, derivatives and amendments are shown separately and are not described as market purchases.
| Transaction / filed | Reporting owner(s) | Code / security | Quantity | Price as filed | Ownership | Source |
|---|---|---|---|---|---|---|
| 2026-10-21Filed 2026-10-22 | OLIVO MARIAOfficer · EVP, ERM & Chief Risk OfficerFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Represents the weighted average sales price for price increments ranging from $398.35 to $398.62. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4. References: F1 | S Sale (market/private)Common Stock · Non-derivative | 15,100D | 398.4441 | Direct | Form 4 ↗0000086312-26-000184 |
| 2026-10-20Filed 2026-10-22 | Klein Michael FrederickOfficer · EVP & President, Personal Ins.Filing contextReported filing row; may be amended. Do not sum filings blindly. F1 Represents the weighted average sales price for price increments ranging from $392.170 to $393.165. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F2 Represents the weighted average sales price for price increments ranging from $393.170 to $393.315. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. References: | M Exercise / conversionStock Options (Right to Buy) · Derivative | 7,500D | 0 | Direct | Form 4 ↗0000086312-26-000183 |
| 2026-10-20Filed 2026-10-22 | Klein Michael FrederickOfficer · EVP & President, Personal Ins.Filing contextReported filing row; may be amended. Do not sum filings blindly. F1 Represents the weighted average sales price for price increments ranging from $392.170 to $393.165. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F2 Represents the weighted average sales price for price increments ranging from $393.170 to $393.315. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. References: F2 | S Sale (market/private)Common Stock · Non-derivative | 1,359D | 393.2592 | Direct | Form 4 ↗0000086312-26-000183 |
| 2026-10-20Filed 2026-10-22 | Klein Michael FrederickOfficer · EVP & President, Personal Ins.Filing contextReported filing row; may be amended. Do not sum filings blindly. F1 Represents the weighted average sales price for price increments ranging from $392.170 to $393.165. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F2 Represents the weighted average sales price for price increments ranging from $393.170 to $393.315. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. References: F1 | S Sale (market/private)Common Stock · Non-derivative | 6,141D | 392.6874 | Direct | Form 4 ↗0000086312-26-000183 |
| 2026-10-20Filed 2026-10-22 | Klein Michael FrederickOfficer · EVP & President, Personal Ins.Filing contextReported filing row; may be amended. Do not sum filings blindly. F1 Represents the weighted average sales price for price increments ranging from $392.170 to $393.165. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F2 Represents the weighted average sales price for price increments ranging from $393.170 to $393.315. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. References: | M Exercise / conversionCommon Stock · Non-derivative | 7,500A | 139.83 | Direct | Form 4 ↗0000086312-26-000183 |
| 2026-09-30Filed 2026-10-01 | Robinson ElizabethDirectorFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 These are deferred common stock units received in lieu of cash compensation pursuant to the Company's Deferred Compensation Plan for Non-Employee Directors. The deferred common stock units will be converted into shares of Company common stock on a one-for-one basis upon distribution. Distribution of shares of common stock occurs, at the election of the director, either in a lump sum or in annual installments pursuant to the Company's Deferred Compensation Plan for Non-Employee Directors. F2 Includes the deferred common stock units granted under one or more of the Company's directors' compensation plans. Also includes 44.05 deferred common stock units acquired on September 30, 2026 pursuant to the dividend reinvestment features of those plans, which will be distributed as described in footnote 1 above. References: F1, F2 | A Award / grantCommon Stock · Non-derivative | 122.72A | 356.51 | Direct | Form 4 ↗0000086312-26-000172 |
| 2026-09-30Filed 2026-10-01 | Jabbour Anthony MDirectorFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 These are deferred common stock units received in lieu of cash compensation pursuant to the Company's Deferred Compensation Plan for Non-Employee Directors. The deferred common stock units will be converted into shares of Company common stock on a one-for-one basis upon distribution. Distribution of shares of common stock occurs, at the election of the director, either in a lump sum or in annual installments pursuant to the Company's Deferred Compensation Plan for Non-Employee Directors. F2 Includes the deferred common stock units granted under one or more of the Company's directors' compensation plans. Also includes 1.564 deferred common stock units acquired on September 30, 2026 pursuant to the dividend reinvestment features of those plans, which will be distributed as described in footnote 1 above. References: F1, F2 | A Award / grantCommon Stock · Non-derivative | 65.17A | 356.51 | Direct | Form 4 ↗0000086312-26-000170 |
| 2026-09-30Filed 2026-10-01 | Golden Russell G.DirectorFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 These are deferred common stock units received in lieu of cash compensation pursuant to the Company's Deferred Compensation Plan for Non-Employee Directors. The deferred common stock units will be converted into shares of Company common stock on a one-for-one basis upon distribution. Distribution of shares of common stock occurs, at the election of the director, either in a lump sum or in annual installments pursuant to the Company's Deferred Compensation Plan for Non-Employee Directors. F2 Includes the deferred common stock units granted under one or more of the Company's directors' compensation plans. Also includes 19.634 deferred common stock units acquired on September 30, 2026 pursuant to the dividend reinvestment features of those plans, which will be distributed as described in footnote 1 above. References: F1, F2 | A Award / grantCommon Stock · Non-derivative | 129.73A | 356.51 | Direct | Form 4 ↗0000086312-26-000168 |
| 2026-08-28Filed 2026-08-31 | OLIVO MARIAOfficer · EVP, ERM & Chief Risk OfficerFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Represents the weighted average sales price for price increments ranging from $369.81 to $369.962. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4. References: F1 | S Sale (market/private)Common Stock · Non-derivative | 6,000D | 369.8575 | Direct | Form 4 ↗0000086312-26-000166 |
| 2026-08-14Filed 2026-08-18 | Jabbour Anthony MDirectorFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Consists of deferred stock units awarded pursuant to the Company's Amended and Restated 2023 Stock Incentive Plan and the Deferred Compensation Plan for Non-Employee Directors. The deferred stock units will be converted into shares of Company common stock on a one-for-one basis upon distribution. Distribution of shares of common stock occurs, at the election of the director, either in a lump sum or in annual installments beginning at least six months following termination of his or her service as a director pursuant to the Company's Deferred Compensation Plan for Non-Employee Directors. References: F1 | A Award / grantCommon Stock · Non-derivative | 446A | 370.36 | Direct | Form 4 ↗0000086312-26-000165 |
| 2026-07-24Filed 2026-07-27 | Yin Daniel Tei-HwaOfficer · EVP & Co-Chief Invest. OfficerFiling contextReported filing row; may be amended. Do not sum filings blindly. References: | M Exercise / conversionStock Options (Right to Buy) · Derivative | 7,153D | 0 | Direct | Form 4 ↗0000086312-26-000158 |
| 2026-07-24Filed 2026-07-27 | Yin Daniel Tei-HwaOfficer · EVP & Co-Chief Invest. OfficerFiling contextReported filing row; may be amended. Do not sum filings blindly. References: | S Sale (market/private)Common Stock · Non-derivative | 7,153D | 387 | Direct | Form 4 ↗0000086312-26-000158 |
| 2026-07-24Filed 2026-07-27 | Yin Daniel Tei-HwaOfficer · EVP & Co-Chief Invest. OfficerFiling contextReported filing row; may be amended. Do not sum filings blindly. References: | M Exercise / conversionCommon Stock · Non-derivative | 7,153A | 140.85 | Direct | Form 4 ↗0000086312-26-000158 |
| 2026-07-24Filed 2026-07-27 | Kurtzman DianeOfficer · EVP & Chief HR OfficerFiling contextReported filing row; may be amended. Do not sum filings blindly. References: | M Exercise / conversionStock Options (Right to Buy) · Derivative | 4,164D | 0 | Direct | Form 4 ↗0000086312-26-000157 |
| 2026-07-24Filed 2026-07-27 | Kurtzman DianeOfficer · EVP & Chief HR OfficerFiling contextReported filing row; may be amended. Do not sum filings blindly. References: | S Sale (market/private)Common Stock · Non-derivative | 4,164D | 386.71 | Direct | Form 4 ↗0000086312-26-000157 |
| 2026-07-24Filed 2026-07-27 | Kurtzman DianeOfficer · EVP & Chief HR OfficerFiling contextReported filing row; may be amended. Do not sum filings blindly. References: | M Exercise / conversionCommon Stock · Non-derivative | 4,164A | 132.58 | Direct | Form 4 ↗0000086312-26-000157 |
| 2026-07-22Filed 2026-07-24 | Rowland David DonnayOfficer · EVP & Co-Chief Invest. OfficerFiling contextReported filing row; may be amended. Do not sum filings blindly. References: | M Exercise / conversionStock Options (Right to Buy) · Derivative | 5,000D | 0 | Direct | Form 4 ↗0000086312-26-000156 |
| 2026-07-22Filed 2026-07-24 | Rowland David DonnayOfficer · EVP & Co-Chief Invest. OfficerFiling contextReported filing row; may be amended. Do not sum filings blindly. References: | S Sale (market/private)Common Stock · Non-derivative | 5,000D | 371.688 | Direct | Form 4 ↗0000086312-26-000156 |
| 2026-07-22Filed 2026-07-24 | Rowland David DonnayOfficer · EVP & Co-Chief Invest. OfficerFiling contextReported filing row; may be amended. Do not sum filings blindly. References: | M Exercise / conversionCommon Stock · Non-derivative | 5,000A | 132.58 | Direct | Form 4 ↗0000086312-26-000156 |
| 2026-07-22Filed 2026-07-24 | Munson Paul E.Officer · SVP & Corp. ControllerFiling contextReported filing row; may be amended. Do not sum filings blindly. References: | M Exercise / conversionStock Options (Right to Buy) · Derivative | 1,525D | 0 | Direct | Form 4 ↗0000086312-26-000154 |
| 2026-07-22Filed 2026-07-24 | Munson Paul E.Officer · SVP & Corp. ControllerFiling contextReported filing row; may be amended. Do not sum filings blindly. References: | S Sale (market/private)Common Stock · Non-derivative | 1,525D | 369.905 | Direct | Form 4 ↗0000086312-26-000154 |
| 2026-07-22Filed 2026-07-24 | Munson Paul E.Officer · SVP & Corp. ControllerFiling contextReported filing row; may be amended. Do not sum filings blindly. References: | M Exercise / conversionCommon Stock · Non-derivative | 1,525A | 126.18 | Direct | Form 4 ↗0000086312-26-000154 |
| 2026-07-22Filed 2026-07-24 | BESSETTE ANDY FOfficer · EVP and Chief Admin OfficerFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Represents the weighted average sales price for price increments ranging from $367.86 to $368.84. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. References: | S Sale (market/private)Common Stock · Non-derivative | 100D | 368.865 | Direct | Form 4 ↗0000086312-26-000152 |
| 2026-07-22Filed 2026-07-24 | BESSETTE ANDY FOfficer · EVP and Chief Admin OfficerFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Represents the weighted average sales price for price increments ranging from $367.86 to $368.84. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. References: F1 | S Sale (market/private)Common Stock · Non-derivative | 2,900D | 368.0865 | Direct | Form 4 ↗0000086312-26-000152 |
| 2026-07-21Filed 2026-07-23 | Klein Michael FrederickOfficer · EVP & President, Personal Ins.Filing contextReported filing row; may be amended. Do not sum filings blindly. F1 Represents the weighted average sales price for price increments ranging from $364.72 to $365.03. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F2 Represents the weighted average sales price for price increments ranging from $365.798 to $366.275. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. References: | M Exercise / conversionStock Options (Right to Buy) · Derivative | 6,000D | 0 | Direct | Form 4 ↗0000086312-26-000150 |
Imported instruments only. Joint owners do not multiply transactions. Amendments are separate filing rows, not additional trades. No aggregate trade totals are implied.